As you may remember, on June 10 I reported on a new FDA warning about high doses of the statin drug Zocor. Now, new findings reported in the Journal of American Medical Association (JAMA) are adding more fuel to that fire—that high-dose statins (80 mg) can increase a patient’s risk of developing Type 2 diabetes.
The Statin and Diabetes Risk
The JAMA study looked at 32,752 patients and compared the diabetes risk for those taking a daily high-dose statin of 80 mg, to those taking lower doses. During the five-year study, 2,749 patients in both the high-dose statin group and the lower-dose statin group developed Type 2 diabetes, but those in the high-dose statin group had a 12% increased risk!
This isn’t the first time we’ve had findings like this. The famous JUPITER study, which was initiated to prove the benefits of statin drugs on patients with low-to-normal LDL cholesterol, was halted because patients were developing diabetes at increased rates.
Plus, this issue of high-dose statins has even touched much closer to home—in my own practice. One of my employee’s fathers had bypass surgery and I recently went over his lab work. He’s on a high-dose statin and both his blood sugar and A1C was elevated—and he’s never had diabetes before. I told my employee her father should cut that high-dose statin in half.
So, what does this mean for you? If you, or someone you know, is on a high-dose statin drug—I urge you to speak with your physician about lowering the dose.
Now It's Your Turn: Did you develop diabetes after taking a high-dose statin?
You May Also Be Interested In: